Oryn Therapeutics, LLC   Report issue

For profit Phase 2
Founded: Vacaville CA United States (2013)

Organization Overview

First Clinical Trial
2020
NCT04286789
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Oryn Therapeutics, LLC

Active Ingredients

Drugs in Phase 2 Trials (1)

ortd-1 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1